In 2019, Trump signed an executive order to lower drug prices, but it was met with opposition from both Democrats and Republicans. Some argued that the plan was too aggressive and could harm innovation in the pharmaceutical industry. Others believed it didn’t go far enough to address the root causes of high drug prices.
But the story doesn’t end there. In 2023, President Joe Biden announced a new plan to lower Rx drug prices. This time, the Democrats were on board, and the plan was met with widespread support. So what changed?
Well, for one thing, the political landscape shifted. With a new administration in the White House, the Democrats were more willing to work with President Biden on this issue. Additionally, the COVID-19 pandemic brought the issue of healthcare to the forefront, and there was a renewed sense of urgency to address the high cost of prescription drugs.
In conclusion, the battle for lower Rx drug prices was a long and winding road. While President Trump did try to lower drug prices during his presidency, the Democrats didn’t go along with him. But in the end, it was a bipartisan effort that finally led to progress on this important issue.
